80 FR 13853 - Administration on Intellectual and Developmental Disabilities, President's Committee for People With Intellectual Disabilities

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living

Federal Register Volume 80, Issue 51 (March 17, 2015)

Page Range		13853-13854
FR Document		2015-06085

The President's Committee for People with Intellectual Disabilities (PCPID) will host a webinar/conference call for its members to discuss the preparation of the 2015 Report to the President (RTP). The topic of the PCPID 2015 RTP will be on the roles of technology in the lives of individuals with intellectual and developmental disabilities and their families. All the PCPID meetings, in any format, are open to the public. This webinar/conference call will be conducted in a discussion format. The public can register to attend this webinar/conference call at https://aoa-events.webex.com/aoa-events/onstage/ g.php?MTID=e88689392224a29b0b0110cff660d3e26.

Federal Register, Volume 80 Issue 51 (Tuesday, March 17, 2015)

[Federal Register Volume 80, Number 51 (Tuesday, March 17, 2015)]
[Notices]
[Pages 13853-13854]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06085]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Community Living


Administration on Intellectual and Developmental Disabilities, 
President's Committee for People With Intellectual Disabilities

AGENCY: Administration for Community Living, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The President's Committee for People with Intellectual 
Disabilities (PCPID) will host a webinar/conference call for its 
members to discuss the preparation of the 2015 Report to the President 
(RTP). The topic of the PCPID 2015 RTP will be on the roles of 
technology in the lives of individuals with intellectual and 
developmental disabilities and their families.
    All the PCPID meetings, in any format, are open to the public. This 
webinar/conference call will be conducted in a discussion format.
    The public can register to attend this webinar/conference call at 
https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.

DATES: Webinar: Tuesday, April 7, 2015 from 1:30 p.m. to approximately 
3:30 p.m.
    Registration for Webinar: March 16, 2015 through April 3, 2015.

ADDRESSES: Webinar Web page: https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.

FOR FURTHER INFORMATION CONTACT: For Reasonable Accomodations Contact: 
Dr. MJ Karimi, PCPID Team Lead, One Massachusetts Avenue NW., Room 
4206, Washington, DC 20201. Email: [email protected]; telephone: 
202-357-3588; fax: 202-205-8037.

SUPPLEMENTARY INFORMATION:
    Background: The PCPID members participated in a face-to-face 
meeting on February 19-20, 2015 and streamlined the process of 
preparing the 2015 RTP. As the Phase I of the process, they decided to 
research four focus areas through the lens of technology. These focus 
areas included:
    1. Education;
    2. Community Living;
    3. Health and Wellness;
    4. Economic Well-Being.
    The members also agreed to reconvene in April, through a webinar/
conference call, to report their findings to the full Committee and 
discuss the development of potential recommendations for inclusion to 
the PCPID 2015 RTP.
    The general purpose of the PCPID webinar/conference call is, thus, 
to present a forum for the members to complete Phase I and discuss the 
next phase of preparing the PCPID 2015 RTP.
    Webinar and Registration: The webinar is scheduled for April 7, 
2015, 1:30 p.m. to 3:30 p.m. (EST) and may end early if discussions are 
finished. Registration for the webinar is required and is open from 
March 16, 2015 to April 3, 2015.
    Instructions to Register in the Webinar/Conference Call on Tuesday 
April 7, 2015:
    1. WebEx Link: https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.
    2. Click on the ``Register'' button on the page.
    3. Enter the required information and click ``Submit.''
    Instructions to Participate in the Webinar/Conference Call on 
Tuesday April 7, 2015:
    4. WebEx Link: https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.
    5. Click on the ``join'' button on the page.
    6. Enter your name and email address.
    7. Follow additional instructions as provided by WebEx. If a 
password is needed for the WebEx link, please enter 123456.
    Call-in number: (888) 469-0957; Pass Code: 8955387 (please put your 
phone on mute during the meeting).
    Background information on PCPID: The PCPID acts in an advisory 
capacity to the President and the Secretary of Health and Human 
Services, through the Administration on Intellectual and Developmental 
Disabilities, on a broad range of topics relating to programs, services 
and supports for persons with intellectual disabilities. The PCPID 
Executive Order stipulates that the Committee shall: (1) Provide such 
advice concerning intellectual disabilities as the President or the 
Secretary of Health and Human Services may request; and (2) provide 
advice to the President concerning the following

[[Page 13854]]

for people with intellectual disabilities: (A) Expansion of educational 
opportunities; (B) promotion of homeownership; (C) assurance of 
workplace integration; (D) improvement of transportation options; (E) 
expansion of full access to community living; and (F) increasing access 
to assistive and universally designed technologies.

    Dated: March 11, 2015.
Aaron Bishop,
Commissioner, Administration on Intellectual and Developmental 
Disabilities.
[FR Doc. 2015-06085 Filed 3-16-15; 8:45 am]
 BILLING CODE 4154-01-P

13854 Federal Register / Vol. 80, No. 51 / Tuesday, March 17, 2015 / Notices

for people with intellectual disabilities: Dated: March 11, 2015. See the SUPPLEMENTARY INFORMATION
(A) Expansion of educational Carolyn Baum, section for electronic access to the
opportunities; (B) promotion of Program Analyst, Office of Federal Advisory Authorization.
homeownership; (C) assurance of Committee Policy. FOR FURTHER INFORMATION CONTACT:
workplace integration; (D) improvement [FR Doc. 2015–05968 Filed 3–16–15; 8:45 am] Luciana Borio, Assistant Commissioner
of transportation options; (E) expansion BILLING CODE 4140–01–P for Counterterrorism Policy, Office of
of full access to community living; and Counterterrorism and Emerging Threats,
(F) increasing access to assistive and and Acting Deputy Chief Scientist, Food
universally designed technologies. DEPARTMENT OF HEALTH AND and Drug Administration, 10903 New
HUMAN SERVICES Hampshire Ave., Bldg. 1, rm. 4340,
Dated: March 11, 2015.
Food and Drug Administration Silver Spring, MD 20993–0002, 301–
Aaron Bishop,
796–8510 (this is not a toll free number).
Commissioner, Administration on Intellectual [Docket No. FDA–2014–N–1206] SUPPLEMENTARY INFORMATION:
and Developmental Disabilities.
[FR Doc. 2015–06085 Filed 3–16–15; 8:45 am] Authorization of Emergency Use of an I. Background
BILLING CODE 4154–01–P
In Vitro Diagnostic Device for Section 564 of the FD&C Act (21
Detection of Ebola Zaire Virus; U.S.C. 360bbb–3) as amended by the
Availability Project BioShield Act of 2004 (Pub. L.
DEPARTMENT OF HEALTH AND AGENCY: Food and Drug Administration, 108–276) and the Pandemic and All-
HUMAN SERVICES HHS. Hazards Preparedness Reauthorization
ACTION: Notice. Act of 2013 (Pub. L. 113–5) allows FDA
National Institutes of Health to strengthen the public health
SUMMARY: The Food and Drug protections against biological, chemical,
National Institute of Neurological Administration (FDA) is announcing the nuclear, and radiological agents. Among
Disorders and Stroke; Notice of Closed issuance of an Emergency Use other things, section 564 of the FD&C
Meeting Authorization (EUA) (the Authorization) Act allows FDA to authorize the use of
for an in vitro diagnostic device for an unapproved medical product or an
Pursuant to section 10(d) of the detection of the Ebola Zaire virus in unapproved use of an approved medical
Federal Advisory Committee Act, as response to the 2014 Ebola virus product in certain situations. With this
amended (5 U.S.C. App.), notice is outbreak in West Africa. FDA is issuing EUA authority, FDA can help assure
hereby given of the following meeting. this Authorization under the Federal that medical countermeasures may be
The meeting will be closed to the Food, Drug, and Cosmetic Act (the used in emergencies to diagnose, treat,
public in accordance with the FD&C Act), as requested by Roche or prevent serious or life-threatening
Molecular Systems, Inc. (Roche). The diseases or conditions caused by
provisions set forth in sections
Authorization contains, among other biological, chemical, nuclear, or
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
things, conditions on the emergency use radiological agents when there are no
as amended. The grant applications and of the authorized in vitro diagnostic
the discussions could disclose adequate, approved, and available
device. The Authorization follows the alternatives.
confidential trade secrets or commercial September 22, 2006, determination by Section 564(b)(1) of the FD&C Act
property such as patentable material, then-Secretary of the Department of provides that, before an EUA may be
and personal information concerning Homeland Security (DHS), Michael issued, the Secretary of HHS must
individuals associated with the grant Chertoff, that the Ebola virus presents a declare that circumstances exist
applications, the disclosure of which material threat against the U.S. justifying the authorization based on
would constitute a clearly unwarranted population sufficient to affect national one of the following grounds: (1) A
invasion of personal privacy. security. On the basis of such determination by the Secretary of
Name of Committee: National Institute of determination, the Secretary of Health Homeland Security that there is a
Neurological Disorders and Stroke Special and Human Services (HHS) declared on domestic emergency, or a significant
Emphasis Panel; NINDS Center Core (P30) August 5, 2014, that circumstances exist potential for a domestic emergency,
and Research Resource (R24) Review. justifying the authorization of involving a heightened risk of attack
Date: April 17, 2015. emergency use of in vitro diagnostics for with a biological, chemical, radiological,
Time: 8:00 a.m. to 6:00 p.m. detection of Ebola virus subject to the or nuclear agent or agents; (2) a
Agenda: To review and evaluate grant terms of any authorization issued under determination by the Secretary of
applications. the FD&C Act. The Authorization, Defense that there is a military
Place: Washington Plaza Hotel, 10 Thomas which includes an explanation of the emergency, or a significant potential for
Circle NW., Washington, DC 20005. reasons for issuance, is reprinted in this a military emergency, involving a
Contact Person: Natalia Strunnikova, document. heightened risk to U.S. military forces of
Ph.D., Scientific Review Officer, Scientific DATES: The Authorization is effective as attack with a biological, chemical,
Review Branch, Division of Extramural of December 23, 2014. radiological, or nuclear agent or agents;
Research, NINDS/NIH/DHHS/Neuroscience ADDRESSES: Submit written requests for (3) a determination by the Secretary of
Center, 6001 Executive Boulevard, Suite single copies of the EUA to the Office HHS that there is a public health
3208, MSC 9529, Bethesda, MD 20892–9529,
mstockstill on DSK4VPTVN1PROD with NOTICES

of Counterterrorism and Emerging emergency, or a significant potential for
301–402–0288, natalia.strunnikova@nih.gov. Threats, Food and Drug Administration, a public health emergency, that affects,
(Catalogue of Federal Domestic Assistance 10903 New Hampshire Ave., Bldg. 1, or has a significant potential to affect,
Program Nos. 93.853, Clinical Research rm. 4338, Silver Spring, MD 20993– national security or the health and
Related to Neurological Disorders; 93.854, 0002. Send one self-addressed adhesive security of U.S. citizens living abroad,
Biological Basis Research in the label to assist that office in processing and that involves a biological, chemical,
Neurosciences, National Institutes of Health, your request or include a fax number to radiological, or nuclear agent or agents,
HHS) which the Authorization may be sent. or a disease or condition that may be

VerDate Sep<11>2014 18:09 Mar 16, 2015 Jkt 235001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\17MRN1.SGM 17MRN1

Document Created: 2015-12-18 12:01:22
Document Modified: 2015-12-18 12:01:22

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Webinar: Tuesday, April 7, 2015 from 1:30 p.m. to approximately 3:30 p.m.
Contact		For Reasonable Accomodations Contact: Dr. MJ Karimi, PCPID Team Lead, One Massachusetts Avenue NW., Room 4206, Washington, DC 20201. Email: [email protected]; telephone: 202-357-3588; fax: 202-205-8037.
FR Citation		80 FR 13853

80 FR 13853 - Administration on Intellectual and Developmental Disabilities, President's Committee for People With Intellectual Disabilities

DEPARTMENT OF HEALTH AND HUMAN SERVICESAdministration for Community Living

Federal Register Volume 80, Issue 51 (March 17, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living